Skip to search formSkip to main contentSkip to account menu

CTTHWGFTLC peptide

Known as: CTT1 peptide, CTTHWGFTLC 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Development of Brain Targeting Peptide Based MMP-9 Inhibiting Nanoparticles for the Treatment of Brain Diseases with Elevated MMP-9 Activity.
2014
2014
Systemic Delivery of Protein Nanocages Bearing CTT Peptides for Enhanced Imaging of MMP-2 Expression in Metastatic Tumor Models
Matrix metalloproteinase 2 (MMP-2) in metastatic cancer tissue, which is associated with a poor prognosis, is a potential target… 
2011
2011
Crucial role of HSP90 in the Akt-dependent promotion of angiogenic-like effect of glucose-regulated protein94 (Grp94)-IgG complexes
Previous observations showed that complexes of glucose‐regulated protein94 (Grp94) with human IgG, both those isolated from… 
2007
2007
Induction of matrix metalloproteinase-2 enhances systemic arterial contraction after hypoxia.
This study was carried out to determine the role of increased vascular matrix metalloproteinase-2 (MMP-2) expression in the… 
2007
2007
Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor.
Development of novel therapy for patients with tumor is still a challenge at the present time. We designed a fusion peptide (RK5… 
Highly Cited
2006
Highly Cited
2006
In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models.
Highly Cited
2002
Highly Cited
2002
Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and…
Bisphosphonates (clodronate, alendronate, pamidronate and zoledronate) at therapeutically attainable non-cytotoxic concentrations… 
Highly Cited
2001
Highly Cited
2001
Binding of novel peptide inhibitors of type IV collagenases to phospholipid membranes and use in liposome targeting to tumor cells in vitro.
We have recently described a novel cyclic peptide inhibitor CTTHWGFTLC (CTT) for matrix metalloproteinases (MMP)-2 and MMP-9… 
Highly Cited
2000
Highly Cited
2000
Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction
Matrix metalloproteinase (MMP)-2 has been historically associated with the process of vascular remodeling through the cleavage of… 
2000
2000
Peptide Promotes Vasoconstriction Dependent Cleavage of Calcitonin Gene-Related − Vascular Matrix Metalloproteinase-2
Matrix metalloproteinase (MMP)-2 has been historically associated with the process of vascular remodeling through the cleavage of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)